ASCORBIC-ACID-MEDIATED IRON RELEASE FROM CELLULAR FERRITIN AND ITS RELATION TO THE FORMATION OF DNA STRAND BREAKS IN NEUROBLASTOMA-CELLS

被引:46
作者
BAADER, SL [1 ]
BRUCHELT, G [1 ]
CARMINE, TC [1 ]
LODE, HN [1 ]
RIETH, AG [1 ]
NIETHAMMER, D [1 ]
机构
[1] UNIV TUBINGEN, CHILDRENS HOSP, DEPT HEMATOL & ONCOL, D-72070 TUBINGEN, GERMANY
关键词
FERRITIN; IRON RELEASE; NEUROBLASTOMA; ASCORBATE; PRO-OXIDATIVE EFFECTS;
D O I
10.1007/BF01240141
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ascorbic acid at pharmacologically attainable concentrations effectively inhibited the growth of the catecholamine-positive neuroblastoma cell line SK-N-SH; it inhibited LS cells to a smaller extent and catecholamine-negative SK-N-LO cell growth least effectively. In all three cell lines high concentrations of H2O2 were found. Since ascorbic acid was shown to release iron from ferritin in vitro and to keep it in the reduced state, we suggested that it acted as a pro-oxidant in ferritin-rich neuroblastoma cells in the presence of H2O2 and Fe2+ (Fenton reaction), implying iron release from cellular ferritin. We show here that iron could be mobilized from cellular ferritin by 1 mM, ascorbic acid in iron-59-preloaded SK-N-SH and LS cells, but not in SK-N-LO cells. In agreement with these results, DNA strand break formation by ascorbate was only observed in SK-N-SH and LS cells. In SK-N-LO cells, DNA strand breaks could be induced by a combination of 1 mM ascorbic acid and 100 mu M H2O2. Since cell-damaging effects caused by chemotherapy further facilitate iron release from ferritin, we conclude that ascorbate could be a powerful enhancer of some cytostatic drugs in neuroblastoma therapy.
引用
收藏
页码:415 / 421
页数:7
相关论文
共 35 条
[1]  
[Anonymous], 2015, FREE RADICAL BIO MED
[2]   A SIMPLE ASSAY FOR DETERMINATION OF IRON RELEASE FROM FERRITIN IN NEUROBLASTOMA-CELLS [J].
BAADER, SL ;
BRUCHELT, G ;
HANDGRETINGER, R ;
NIETHAMMER, D .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 1992, 25 (01) :11-15
[3]  
BIEDLER JL, 1973, CANCER RES, V33, P2643
[4]  
BIRNBOIM HC, 1981, CANCER RES, V41, P1889
[5]   SUPEROXIDE ION AS A PRIMARY REDUCTANT IN ASCORBATE-MEDIATED FERRITIN IRON RELEASE [J].
BOYER, RF ;
MCCLEARY, CJ .
FREE RADICAL BIOLOGY AND MEDICINE, 1987, 3 (06) :389-395
[6]  
BRUCHELT G, 1991, CANCER RES, V51, P6066
[7]   IN THE ABSENCE OF CATALYTIC METALS ASCORBATE DOES NOT AUTOXIDIZE AT PH-7 - ASCORBATE AS A TEST FOR CATALYTIC METALS [J].
BUETTNER, GR .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 1988, 16 (01) :27-40
[8]   IMMUNOHISTOCHEMICAL STAINING FOR FERRITIN IN NEUROBLASTOMAS [J].
CARTER, RL ;
HALL, JM ;
CORBETT, RP .
HISTOPATHOLOGY, 1991, 18 (05) :465-468
[9]   CELLULAR INJURY BY OXIDANTS [J].
COCHRANE, CG .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S23-S30
[10]  
Fenton HJH., 1984, J CHEM SOC T, V65, P899, DOI DOI 10.1039/CT8946500899